THBS1 mRNA expression levels also significantly correlate with poor prognosis for ovarian carcinoma patients (Figure 2f), while both THBS1 and CD47 expression are associated with being decreased overall, as well as progression free survival (Figure 2g,h). Here, THBS1 is linked to ovarian carcinoma.